Besides PD-L1, where a significant reduction between plasma and exosome-depleted plasma was visible in HNSCC patients and in HD, for all other checkpoint molecules this observation was only made in HNSCC patients, indicating elevated surface levels in HNSCC plasma-derived exosomes (Fig. 2). This evidence concerns the gene CD274 and Huntington disease.